Evidence map›Paper›PMID 34502263›Full record

ArticleInternational journal of molecular sciences2021

RGS5 Determines Neutrophil Migration in the Acute Inflammatory Phase of Bleomycin-Induced Lung Injury.

Neha Sharma, Chandran Nagaraj, Bence M Nagy, Leigh M Marsh, Natalie Bordag, Diana Zabini, Malgorzata Wygrecka, Walter Klepetko, Elisabeth Gschwandtner, Guillem Genové and 5 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Neha SharmaLudwig Boltzmann Institute for Lung Vascular Research, 8010 Graz, Austria.
Chandran NagarajLudwig Boltzmann Institute for Lung Vascular Research, 8010 Graz, Austria.
Bence M NagyLudwig Boltzmann Institute for Lung Vascular Research, 8010 Graz, Austria.ORCID 0000-0003-3955-4863
Leigh M MarshLudwig Boltzmann Institute for Lung Vascular Research, 8010 Graz, Austria.ORCID 0000-0002-1754-9249
Natalie BordagLudwig Boltzmann Institute for Lung Vascular Research, 8010 Graz, Austria.ORCID 0000-0002-9505-6271
Diana ZabiniLudwig Boltzmann Institute for Lung Vascular Research, 8010 Graz, Austria.
Malgorzata WygreckaCenter for Infection and Genomics of the Lung (Member of the German Center for Lung Research), University of Giessen, Giessen 35392, Germany.ORCID 0000-0002-3656-2932
Walter KlepetkoDepartment of Thoracic Surgery, Medical University of Vienna, 1090 Vienna, Austria.
Elisabeth GschwandtnerDepartment of Thoracic Surgery, Medical University of Vienna, 1090 Vienna, Austria.
Guillem GenovéIntegrated CardioMetabolic Centre (ICMC), Department of Medicine, Karolinska Institute, 171 77 Huddinge, Sweden.ORCID 0000-0002-8558-3107
Akos HeinemannOtto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, 8010 Graz, Austria.ORCID 0000-0002-8554-2372
E Kenneth WeirDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Grazyna KwapiszewskaLudwig Boltzmann Institute for Lung Vascular Research, 8010 Graz, Austria.
Horst OlschewskiLudwig Boltzmann Institute for Lung Vascular Research, 8010 Graz, Austria.ORCID 0000-0002-2834-7466
Andrea OlschewskiLudwig Boltzmann Institute for Lung Vascular Research, 8010 Graz, Austria.ORCID 0000-0002-8189-3634
Medical University of Graz · ATLudwig Boltzmann Institute for Lung Vascular Research · ATMedical University of Vienna · ATJustus-Liebig-Universität Gießen · DEKarolinska Institutet · SEUniversity of Minnesota · US

Funding

Medical University of Graz PhD Program Molecular Medicine (MolMed)
6 · The paper itself

Abstract

The regulator of G protein signaling (RGS) represents a widespread system of controllers of cellular responses. The activities of the R4 subfamily of RGSs have been elucidated in allergic pulmonary diseases. However, the R4 signaling in other inflammatory lung diseases, with a strong cellular immune response, remained unexplored. Thus, our study aimed to discern the functional relevance of the R4 family member, RGS5, as a potential modulating element in this context. Gene profiling of the R4 subfamily showed increased RGS5 expression in human fibrosing lung disease samples. In line with this, RGS5 was markedly increased in murine lungs following bleomycin injury. RGS knock-out mice (RGS-/-) had preserved lung function while control mice showed significant combined ventilatory disorders three days after bleomycin application as compared to untreated control mice. Loss of RGS5 was associated with a significantly reduced neutrophil influx and tissue myeloperoxidase expression. In the LPS lung injury model, RGS5-/- mice also failed to recruit neutrophils into the lung, which was accompanied by reduced tissue myeloperoxidase levels after 24 h. Our in-vitro assays showed impaired migration of RGS5-/- neutrophils towards chemokines despite preserved Ca

Indexed as

AnimalsBleomycinChemotaxisDisease Models, AnimalFibrosisHumansInflammationLipopolysaccharidesLung Diseases, InterstitialLung InjuryMAP Kinase Signaling SystemMiceMice, KnockoutNeutrophilsRespiratory Distress SyndromeRGS ProteinsBleomycinLipopolysaccharidesRGS5 protein, humanRgs5 protein, mouseRGS ProteinschemotaxisERKinterstitial lung diseasesneutrophilic inflammationregulator of G protein signaling 5

Identifiers

PMID34502263
PMCPMC8430858
OpenAlexW3197459508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.